Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

Amgen lands first FDA approval for drug targeting elusive mutation in lung cancer
MedCity News
Sat, 05/29/21 - 04:52 pm
Tags:
Amgen, FDA, sotorasib, Lumakras, KRAS mutation
Sandoz's Enbrel biosim case turned away at SCOTUS, giving Amgen's blockbuster 8 more years of free rein
Fierce Pharma
Mon, 05/17/21 - 10:59 pm
Tags:
Novartis, Sandoz, generics, Supreme Court, Amgen, Embrel, biosimilar
ACC 2021: With Amgen out of the picture, Cytokinetics imagines supporting role for omecamtiv in heart failure
Fierce Biotech
Mon, 05/17/21 - 10:48 am
Tags:
Amgen, Cytokinetics, ACC, Omecamtiv Mecarbil
Amgen, AstraZeneca's tezepelumab is looking for a slice of blockbuster asthma market dominated by Sanofi's Dupixent
Fierce Biotech
Thu, 05/13/21 - 10:57 am
Tags:
Amgen, AstraZeneca, tezepelumab, asthma, severe asthma, Sanofi, Dupixent, FDA
Amgen asks FDA for approval of key asthma drug
BioPharma Dive
Mon, 05/10/21 - 08:15 pm
Tags:
Amgen, FDA, asthma, tezepelumab
Pandemic slowed sales of cancer, arthritis, diabetes drugs
Beckers Hospital Review
Mon, 05/3/21 - 10:48 am
Tags:
COVID-19, pandemic, cancer, diabetes, arthritis, Merck, Keytruda, Amgen, Enbrel
Amgen’s low-dose Kras curveball
EP Vantage
Thu, 04/29/21 - 10:40 am
Tags:
Amgen, FDA, Lumakras, sotorasib
Why Amgen's Q1 Results Disappointed Investors
Motley Fool
Wed, 04/28/21 - 10:18 am
Tags:
Amgen, earnings
Bris­tol My­er­s' next-gen im­munol­o­gy med busts Am­gen's Ote­zla in head-to-head study. Is a show­down com­ing?
Endpoints
Fri, 04/23/21 - 11:12 am
Tags:
Bristol Myers Squibb, biologics, psoriasis, Amgen, deucravacitinib, Otezla
The retreat of corporate venture funding?
EP Vantage
Fri, 04/23/21 - 11:02 am
Tags:
funding, venture funding, venture capital, AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, GSK, JNJ, Merck, Merck KGaA, Pfizer, Roche, Sanofi, Takeda
Am­gen's promis­ing gas­tric can­cer drug makes good on Five Prime po­ten­tial with FDA's break­through nod
Endpoints
Tue, 04/20/21 - 11:13 am
Tags:
Amgen, clinical trials, gastric cancer, bemarituzumab, FDA
Quiet times return for biopharma takeouts
EP Vantage
Wed, 04/14/21 - 09:26 am
Tags:
M&A, Alexion, Amgen, AstraZeneca, Biogen, Five Prime Therapeutics, Gilead Sciences, GW Pharma, Horizon Therapeutics, Immunomedics, Jazz Pharmaceutical, Kymab, Merck, Pandion, Sanofi, Viela Bio
Anti-aging biotech upstart plucks a drug from Amgen's discard pile, pivoting from heart failure to muscle conditions
Endpoints
Wed, 04/14/21 - 09:24 am
Tags:
BioAge Labs, Amgen, AMG 986, BGE-105
With sales on the upswing, Amgen CEO Bradway scores a $20M pay package for 2020
Fierce Pharma
Tue, 04/6/21 - 10:57 pm
Tags:
Amgen, Bob Bradway, Pharma CEOs, executive pay
Amgen drops $55M upfront for Rodeo Therapeutics and its prostaglandin blockers
Fierce Biotech
Tue, 03/30/21 - 10:23 pm
Tags:
Amgen, Rodeo Therapeutics, M&A
Amgen v Sanofi ruling: It is time to kiss goodbye to broad, functional patent claims for antibodies
Biopharma Reporter
Thu, 03/25/21 - 11:52 am
Tags:
Amgen, Sanofi, patents, antibodies, intellectual property
How Five Prime suitor Amgen battled multiple companies for the biotech—and won
Fierce Biotech
Fri, 03/19/21 - 10:48 am
Tags:
Amgen, M&A, Five Prime Therapeutics, SEC, oncology
Lilly rejoins KRAS race with swipe at Amgen and Mirati, plans 2021 clinical trial
Fierce Biotech
Thu, 03/11/21 - 10:47 am
Tags:
Eli Lilly, KRAS, Amgen, Mirati Therapeutics, LY3499446, solid tumors
Amgen adds gastric cancer drug candidate in $1.9 billion Five Prime Therapeutics deal
Reuters
Thu, 03/4/21 - 10:29 am
Tags:
Amgen, Five Prime Therapeutics, M&A, gastric cancer
While Life Sciences Industry Remains Strong, Some Big Names Face Layoffs
BioSpace
Tue, 03/2/21 - 12:15 pm
Tags:
COVID-19, pandemic, layoffs, Gilead Sciences, Amgen, GSK, Sanofi, Viatris

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.